The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial

•This was a randomised, positive drug-controlled study with a non-inferior design.•This study evaluated the efficacy of keverprazan-based quadruple therapy for Helicobacter pylori infection.•A regimen of keverprazan 20 mg twice daily proved to be effective against H. pylori.•The eradication rate wit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of antimicrobial agents 2024-11, Vol.64 (5), p.107320, Article 107320
Hauptverfasser:	Tan, Niandi, Wu, Hao, Lan, Cheng, Liu, Chengxia, Liao, Aijun, Jiao, Zhiyong, Su, Dongxing, Zhang, Xiaomei, Zhang, Zhe, Xiao, Weiming, Li, Fangfang, Li, Xing, Xia, Min, Qiu, Rongyuan, Chen, Huixin, Liu, Youli, Su, Mei, Chen, Minhu, Xiao, Yinglian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Amoxicillin - administration & dosage Amoxicillin - therapeutic use Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Clarithromycin - therapeutic use Double-Blind Method Drug Therapy, Combination Esomeprazole Esomeprazole - administration & dosage Esomeprazole - therapeutic use Female Helicobacter Infections - drug therapy Helicobacter pylori - drug effects Helicobacter pylori eradication Humans Keverprazan Male Middle Aged Potassium-competitive acid blocker Proton Pump Inhibitors - administration & dosage Proton Pump Inhibitors - adverse effects Proton Pump Inhibitors - therapeutic use Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!